Clinical Trial Begins for Vitamin-Based Glaucoma Therapy Targeting Retinal Metabolism

Karolinska Institutet researchers are testing a B vitamin and choline supplement shown to slow optic nerve damage in animals, offering a potential new pathway for glaucoma treatment beyond pressure management.